Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom duration
A systematic review and meta-analysis led by Shandong University in China has evaluated the comparative efficacy and safety ...
US FDA declines to approve Atara Biotherapeutics' cancer therapy
The U.S. Food and Drug Administration on Thursday declined to approve Atara Biotherapeutics' therapy to treat patients with a ...